Click Here to find out more
Related products
$38.00
$125.00
Out of stock
$70.00
$110.00
$60.00
$60.00
$50.00
$88.00
Ashford Medical Singapore
Download The Ashford Healthcare App NowNo products in the cart.
No products in the cart.
$45.00
With Metafolin® L-5-MTHF; broad-spectrum B vitamin support
Out of stock
Click Here to find out more
Download The Ashford Healthcare App Now
Age Group:
Infants 12 months and above, Children and Adults
Indications:
M-M-R (Measles, Mumps, and Rubella Virus Vaccine Live, MSD) is a live virus vaccine for vaccination against measles (rubeola), mumps and rubella (German measles).
Doses:
Infants:
First Dose – 12 months
Second Dose – 15 months
Children:
First Dose – On elected date
Second dose – 1 month later
Adults:
One Dose. A second dose would be recommended if patient poses a high risk to measles or mumps transmission.
Side Effects:
Contraindication:
Age Group:
Adult and Children above 6 months old
Indications:
FLUARIX TETRA is indicated for active immunisation of adults and children from 6 months of age for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B virus types contained in the vaccine.
Important to note: The flu vaccine may contain egg protein and is not suitable for individuals who are allergic to it.
Doses:
Infants 6 months to Children less than 9 years:
First Dose – On elected date.
Second Dose – 1 month after the first dose
Adults:
One Dose
Side Effects:
Contraindication:
Age Group:
Adults 18 years and above
Indications:
TWINRIX® 3 is indicated for active immunization against disease caused by hepatitis A virus and 4 infection by all known subtypes of hepatitis B virus.
Doses:
First Dose – On elected date
Second Dose – 1 month later from first dose
Third Dose – 6 months later from second dose
Side Effects:
Contraindication:
Age Group:
Infants and Children 12 months to 12 years of age
Adolescents and Adults 13 years of age and above
Indications:
VARIVAX is indicated for vaccination against varicella in individuals 12 months of age and older.
Doses:
Children above 12 months:
First Dose – On elected date
Second Dose – 3 months from first dose
Adolescents and Adults:
First Dose – On elected date
Second Dose – 4 to 8 weeks later
Side Effects:
Contraindication:
Age Group:
Adults 50 years and above
Indications:
ZOSTAVAX is indicated for prevention of herpes zoster (“zoster” or shingles) and herpes zoster-related post-herpetic neuralgia (PHN) and for reduction of acute and chronic zoster-associated pain.
Doses:
One Dose needed
Side Effects:
Contraindication:
Age Group:
Adult, Children 14 years and above
Indications:
Doses:
First Dose – On elected date
Second Dose – 2 months from the first dose
Third Dose – 6 months from the second dose
Side Effects:
Contraindication:
Age Group:
Adults
Indications:
Tetanus prevention and, in particular: Post-exposure tetanus prophylaxis for recent wounds that may have been contaminated with tetanus spores in subjects who have not had any primary vaccination or for whom primary vaccination is incomplete or uncertain; Neonatal tetanus prophylaxis in non-immunised women either of childbearing age or pregnant in countries where neonatal tetanus is frequent; Primary vaccination; Booster injections.
Doses:
Anti infectious vaccine indicated in the prevention of tetanus.
Side Effects:
Contraindication:
Age Group:
12 months to 12 years old
Indications:
Requires 2 doses, 6 month intervals.
Hepatitis A vaccine (Havrix) is used to prevent hepatitis A, a type of liver disease that is caused by the hepatitis A virus (HAV). Hepatitis A is usually spread when a person ingests fecal matter from contact with food, drinks, or objects which have been contaminated by feces or stool of an HAV-infected person.
Doses:
First Dose – On elected date
Second Dose – 6 months from first dose
Side Effects:
Contraindication:
Age Group:
Adults 19 years and above
Indications:
Requires 2 doses, 6 month intervals.
Hepatitis A vaccine (Havrix) is used to prevent hepatitis A, a type of liver disease that is caused by the hepatitis A virus (HAV). Hepatitis A is usually spread when a person ingests fecal matter from contact with food, drinks, or objects which have been contaminated by feces or stool of an HAV-infected person.
Doses:
First Dose – On elected date
Second Dose – 6 months from first dose
Side Effects:
Contraindication:
Age Group:
Infants 2 months and above
Indications:
Doses:
Infants:
First Dose – 2 months
Second Dose – 4 months
Third Dose – 6 months
Children:
One Dose if recommended
Adult:
One Dose if recommended
Side Effects:
Contraindication:
Age Group:
Infants 2 months and above
Indications:
Doses:
Infants:
First Dose – 2 months
Second Dose – 4 months
Third Dose – 6 months
Children:
One Dose if recommended
Adult:
One Dose if recommended
Side Effects:
Contraindication:
Age Group:
Adult 20 years and above
Indications:
Engerix B is indicated for immunisation against infection caused by all known subtypes of Hepatitis B virus
Doses:
First Dose – On elected date.
Second Dose – 1 month after the first dose.
Third Dose – 6 months after the second dose
Side Effects:
Contraindication:
Age Group:
Adult and Children;10 years and above
Indications:
Boostrix is a vaccine that’s used to help prevent diseases tetanus, diphtheria and pertussis (whooping cough).
Doses:
One Dose after the age of 10 years if child completed childhood vaccination schedule according to NIR
Side Effects:
Contraindication:
Age Group:
Adult and Children above 4 Months Old
Indications:
Prevenar 13 ®️ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM 197 Protein ]) is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F).
Doses:
Children above 4 months
First Dose – 4 months of age
Second Dose – 6 months of age
Third Dose – 12 months of age
Children aged 12 to 23
months:
First Dose – On elected date
Second Dose – 2 months from first dose
Adults and Children aged 2 to 17
years:
One Dose
Side Effects:
Contraindication:
